2018
$100M
from 16 investors over 16 rounds
TScan Therapeutics raised $60M on September 12, 2022
Investors: K2 HealthVentures
TScan Therapeutics raised $100M on January 25, 2021
Investors: 6 Dimensions Capital, GV, Longwood Fund, Pitango Venture Capital, Bessemer Venture Partners and RA Capital Management, L.P.
TScan Therapeutics raised $35M on January 10, 2020
Investors: Astellas Venture Capital L.L.C., 6 Dimensions Capital, Pitango Venture Capital, Longwood Fund, Bessemer Venture Partners and GV
TScan Therapeutics raised undisclosed on July 24, 2019
Investors: GV, Longwood Fund and Bessemer Venture Partners